Clinical trial
Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or…
NCT00416663 · TheraVitae Ltd., Industry · Unknown status
Key facts
| NCT number | NCT00416663 |
|---|---|
| Title | Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure |
| Official title | A Study for Testing Efficacy and Safety of the Administration of Vescell(TM) (Blood-Borne Autologous Angiogenic Cell Precursors) to Alleviate Anginal Symptoms and Myocardial Ischemia in Severe Anginal Syndrome +/- Heart Failure |
| Lead sponsor | TheraVitae Ltd., Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Angina Pectoris |
| Intervention type | Procedure |
| Interventions | Intracoronary administration of autologous ACPs |
| Enrollment | 10 |
| Start date | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Dec 28, 2006 |
| Last update posted | Sep 3, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: